xamoterol has been researched along with acebutolol in 7 studies
| Studies (xamoterol) | Trials (xamoterol) | Recent Studies (post-2010) (xamoterol) | Studies (acebutolol) | Trials (acebutolol) | Recent Studies (post-2010) (acebutolol) |
|---|---|---|---|---|---|
| 269 | 80 | 17 | 899 | 266 | 56 |
| Protein | Taxonomy | xamoterol (IC50) | acebutolol (IC50) |
|---|---|---|---|
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.731 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Abrahamsson, T | 1 |
| Ormiston, T; Salpeter, E; Salpeter, S | 2 |
2 review(s) available for xamoterol and acebutolol
| Article | Year |
|---|---|
Cardioselective beta-blocker use in patients with reversible airway disease.
Topics: Acebutolol; Adrenergic beta-Antagonists; Asthma; Celiprolol; Female; Forced Expiratory Volume; Humans; Male; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Xamoterol | 2001 |
Cardioselective beta-blockers for reversible airway disease.
Topics: Acebutolol; Adrenergic beta-Antagonists; Asthma; Celiprolol; Female; Forced Expiratory Volume; Humans; Male; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Xamoterol | 2002 |
5 other study(ies) available for xamoterol and acebutolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Characterization of the beta 1-adrenoceptor stimulatory effects of the partial beta 1-agonists acebutolol, xamoterol, H142/08 and H201/70.
Topics: Acebutolol; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Female; Heart; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Propanolamines; Rats; Renin; Uterine Contraction; Xamoterol | 1989 |